Leeds Janet 4

What Happened

• Janet Leeds, a director of Penumbra, Inc. (PEN), received a grant of 589 restricted stock units (RSUs) on February 13, 2026. The units were reported as acquired at $0.00 (no cash paid); the Form 4 transaction type is an award/grant (code A).

Key Details

• Transaction date and price: 2026-02-13, 589 RSUs at $0.00 each.
• Vesting: RSUs vest 1/4 on each of Mar 31, Jun 30, Sep 30 and Dec 31, 2026, subject to continued service (see footnote). If the merger closing (Agreement and Plan of Merger dated Jan 14, 2026 with Boston Scientific) occurs before full vesting, any unvested RSUs will fully vest on the Closing, subject to continued service.
• Amount owned after the transaction: not disclosed in the provided filing details.
• Filing timeliness: Form filed with the SEC on 2026-02-18 for a 2026-02-13 transaction — this is one business day after the standard two-business-day deadline (late filing).
• No 10b5-1 plan, tax-withholding sale, or immediate cashless sale noted in the provided data.

Context

• RSUs are a common form of equity compensation that typically vest over time or upon a change-of-control; receiving RSUs is neutral — not a market purchase or sale — and is usually part of compensation or retention.
• The merger-related acceleration provision means these RSUs could vest sooner if the Boston Scientific closing occurs, which is standard in merger-related retention arrangements.